A B S T R A C T The pathogenesis of the increased erythrocytosis and extramedullary erythropoiesis observed in infants of diabetic mothers (IDM) has been obscure. In the present studies, IDM were found to have elevated umbilical plasma erythropoietin (Ep) concentrations by radioimmunoassay. 22 of 61 IDM (36%) had levels above the range of28 nonasphyxiated, appropriately grown normal infants. In 16 controls and 20 IDM, plasma Ep correlated directly with plasma insulin (P < 0.001, r = 0.73). To investigate this relationship further, a chronic rhesus model was studied with continuous fetal hyperinsulinemia for 21 d in utero in the last third ofpregnancy. In five experimental fetuses, plasma insulin levels averaged 4,210 ,u.U/ml at delivery, whereas plasma Ep was above the range of six controls. In addition, the experimental fetuses had elevated reticulocyte counts in umbilical cord blood. The mechanism for the increased plasma Ep associated with hyperinsulinemia in the fetus is unexplained but may be mediated by fetal hypoxia.
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(IDM)' (1) (2) (3) . Fetal hypoxia, which may be secondary to placental insufficiency, has been suggested as the cause for this increase in erythropoiesis in IDM (4) .
Because the humoral control of erythropoiesis is dependent on erythropoietin (Ep) production in the fetus as well as the adult, we studied Ep levels in umbilical plasma from infants of normal and diabetic mothers. In addition, because fetal hyperinsulinemia is the major factor responsible for fetal macrosomia and cellular proliferation in IDM (5, 6) , the relationship of fetal insulin and Ep was also investigated in a hyperinsulinemic fetal rhesus monkey (Macaca mulatta) model, in which all the mothers were nondiabetic (7) . METHODS Human studies. Written informed consent was obtained from all study mothers. Two groups of subjects were studied, control infants and IDM. Controls were those singleton births whose birthweights were appropriate for gestational age (>10th percentile and <90th percentile) (8) , whose APGAR scores were .7 at 5 min of life, and whose mothers were not known to have diabetes. The IDM group was likewise selected for being singleton and nonasphyxiated at birth, but not for appropriateness of birthweight. The mothers of these babies were subgrouped according to the earlier modified classification ofWhite (9) . This classification was based on both severity and duration ofdiabetes. The mildest group, class A, included those women with glucose intolerance but without insulin requirements, whereas those in classes D and F/R included those insulin-dependent women who manifested vascular disease. Women from classes B and C required insulin but had no evidence of vascular disease.
Mixed umbilical cord plasma or serum, which had been refrigerated as whole blood for <24 h, was separated, frozen (-20°C) and saved for Ep determination. A doubly clamped umbilical cord blood sample was obtained within 15 s of delivery in a subgroup of 34 IDM and 5 controls. In these individuals, heparinized umbilical venous whole blood was analyzed for hemoglobin concentration, volume of packed erythrocytes, nucleated erythrocyte count (NRBC), reticulocyte count, and total erythrocyte count (RBC) by the usual laboratory procedures. In addition, for these IDM delivered by cesarean section, umbilical arterial and venous blood gases were analyzed using the Coming 164/2 Blood Gas Analyzer (Coming Glass Works, Coming, N. Y.).
Plasma glucose was measured using a glucose oxidase method (YSI 23A Yellow Springs Instrument Co., Yellow Springs, Ohio) and insulin by a double antibody radioimmunoassay technique of Hales and Randle (10) . Only offspring of White's diabetic classes A and A/B2 were evaluated for venous plasma insulin levels, since plasma from these infants do not have matemal antiinsulin antibodies that cross the placenta and interfere with the insulin assay.
Mixed umbilical serum as well as venous plasma was analyzed for Ep using a specific double antibody radioimmunoassay technique (11 Umbilical cord Ep values determined by radioimmunoassay for the two study groups are portrayed in Fig. 1 . Because of the extreme range of values (5-30,000 mU/ml), the vertical axis for Ep is presented on a log scale for graphic purposes. Statistical comparison of the two groups using the Wilcoxon rank-sum test for nonparametric distributions is significant at P < 0.01. 22 of the 61 IDM (36%) fell above the range for the controls (5-69 mU/ml). The three highest Ep values in the IDM group, 30,000, 17,000, and 6,200 mU/ml, were corroborated using the polycythemic mouse bioassay in which the Ep values were 20,000, 13,100, and 5,000 mU/ml, respectively. These three infants were born of mothers from White's classes B (two) and D and, therefore, were not only from the groups with the most severe diabetes. Although significant differences in Ep values were noted when controls were compared with IDM of White's classes A, A/B, C, and D (P < 0.02) (classes B and F/R were too small in number to reach significance), no differences of Ep levels were evident between pairings of diabetic subgroups.
The two subsets of control and IDM subjects (class A and A/B only) who were studied with glucose, insulin, and Ep measurements at the time of delivery are portrayed in Table II In review of the data in mothers' and infants' charts, few differences could be ascertained in comparisons of the IDM with the controls. In addition, those 22 IDM whose Ep values were above the control range (>69 mU/ml) were compared with those 39 IDM within the normal range. There were no differences for the maternal features of age, parity, or smoking history. Cesarean section was, however, more common in the IDM group (P < 0.02 by chi-square). For the infants, no differences could be found for the placental weight or 5-min APGAR scores. However, the IDM with elevated Ep values also had significantly higher birthweight to placental weight ratios compared with IDM with normal Ep levels (P < 0.02). Furthermore, the Fig. 2 shows the results of the fetal rhesus monkey experiments with respect to the glucose, insulin, and Ep values measured in umbilical arterial plasma at the time of delivery. Both groups of fetuses were born of nondiabetic normal mothers. The fetal artterial plasma insulin levels achieved in the five hyperinsulinemic fetuses were two logs higher (2,900-5,300 ,uU/ml) than the controls (29-64 ,uU/ml) with no overlapping of values. Arterial plasma glucose levels were lower (P < 0.03) in the hyperinsulinemic group, but whether this finding per se had any adverse physiologic effect is questionable, since simultaneously obtained umbilical venous glucose values were not different between the groups (7). Similarly, the hyperinsulinemic fetuses manifest plasma Ep levels that were one order ofmagnitude higher than the controls and without overlap. The level for the six control fetuses (8-45 mU/ml) fell within the range ofthose obtained from the control human subjects (8-69 mU/ml). The plasma glucagon levels in the hyperinsulinemic group were lower than the controls, also with no overlap of values.
Parameters of fetal erythropoiesis for both groups of monkeys are shown in Fig. 3 . There was a tendency towards increased hepatic extramedullary erythropoiesis and absolute number of NRBC in the hyperinsulinemic group, but this did not reach the 5% level 3 Rhesus fetus parameters oferythropoiesis: hepatic extramedullary erythropoiesis (EME) (P < 0.06), umbilical vein NRBC (P < 0.08), reticulocytes (P < 0.007) and RBC. (See legend for Fig. 2.) of significance in these small groups. Reticulocytes were, however, increased in the experimental group, while RBC was no different between the two groups.
As shown in Fig. 4 , the body, placenta, and organ weights of the hyperinsulinemic fetuses were heavier than their control counterparts with the exception ofthe kidneys. The ratio of body weight to placenta weight was no different between the two groups. There were no differences in the free-flowing umbilical arterial or venous blood gases between the groups with respect to Po2, Pco2, or pH. DISCUSSION Ep is the major hormonal regulator of erythropoiesis in the mammalian fetus and infant (16) . In the present study, Ep was found to be elevated in umbilical plasma at delivery of infants of diabetic mothers. In one-third The fetus and newborn of the diabetic mother are subject to the altered maternal substrate milieu that can affect a variety of developing fetal systems (17) . Most data have been interpreted to support the concept that maternal hyperglycemia results in fetal hyperglycemia, which stimulates fetal insulin production and release (5) . Fetal hyperinsulinemia in the presence ofadequate substrate produces macrosomia and selective organomegaly (7) . Although several of the diverse complications of the infant of the diabetic mother have been related to fetal hyperinsulinemia, the etiology of some problems including polycythemia and extramedullary erythropoiesis has remained obscure (17) . The finding of elevated plasma Ep in IDM and the correlation of umbilical plasma Ep with timbilical insulin in control and class A and A/B IDM may be interpreted as evidence supporting another role for fetal hyperinsulinemia.
In a small study of eight IDM, Finne could not detect any abnormality in umbilical plasma Ep using a mouse bioassay system (18) . In contrast, the present study included several infants whose Ep levels, when measured by both polycythemic mouse bioassay and radioimmunoassay, were extraordinarily high. It is unclear why certain infants had such high levels. As yet there is no evidence to support the possibility of an increased Ep production in contrast to a relative decrease in Ep receptors, which would permit the accumulation of exceptionally high circulating levels. The differences in magnitude of Ep levels observed in the IDM subjects compared with the hyperinsulinemic rhesus fetuses may be related to species differences, the limited number of rhesus fetuses studied, or unknown adverse uteroplacental factors present in the human diabetic subjects.
Unlike the human IDM, the experimental fetal monkey has been made hyperinsulinemic in utero within a metabolically normal mother. Under these conditions, it is unlikely that fetal hypoxia occurs secondary to maternal/placental insufficiency. However, the increased erythropoiesis and elevated Ep levels observed in the hyperinsulinemic fetal monkeys might result from fetal hypoxia secondary to hyperinsulinemia. Carson et al. (19) have recently observed that hyperinsulinemic fetal sheep have a progressive decrease in arterial oxygen content over several days possibly due to increased fetal and/or placental oxygen consumption or to a decrease in umbilical blood flow (19) .
Since the hyperinsulinemic monkey fetus is macrosomic and has hepatosplenomegaly (7) , a hypoxic stimulus for Ep production may occur secondarily to the increased cellular proliferation. Alternatively, Ep production in the fetus might be directly stimuliated by insulin. Golde et al. (20) have demonstrated that a variety of nonhematologic hormones, e.g. growth hormone, thyroxin, and prolactin may stimulate murine and human bone marrow erythroid progenitors in vitro (20) . In addition, insulin alone was shown to have some stimulatory effect in vitro on Friend erythro-leukemia cells. Zanjani et al. (21) have recently demonstrated in vivo that the increased erythropoiesis produced by testosterone and thyroxine in the fetal sheep is Ep mediated (21) .
In the present studies, the hyperinsulinemic rhesus fetus with increased erythropoiesis and Ep levels had low plasma glucagon concentrations. Naets and Gans (22) have suggested from recent studies ofrats and mice that increased glucagon may have an inhibitory role in the control of erythropoiesis (22) . Whether decreased glucagon would result in enhanced erythropoiesis in the presence of Ep has not yet been established.
Studies involving extirpation of the kidneys and/or liver in the sheep fetus haye localized the site of Ep production to the liver (21, 23, 24) . However, there is little data from direct organ extraction of Ep in the fetus. In contrast, the adult can produce Ep from extrarenal sites under unusual conditions (25) .
In the present study, the ,elevated Ep levels did not correlate with the RBC in either the IDM or the hyperinsulinemic fetal monkeys. This could be due to a mild, compensated hemolytic state and/or to ineffective erythropoiesis. The increased pulmonary excretion of carbon monoxide, an index of bilirubin production, observed by Stevenson et al. (26) in IDM may also reflect ineffective erythropoiesis or hemolysis. Although the hyperinsulinemic fetal monkeys had suggestive increases in erythropoiesis correlating well with increased Ep levels, measurements of erythrocyte production with ferrokinetics, and of erythrocyte survival may further elucidate this problem.
In summary, the rhesus and human umbilical plasma data on Ep levels presented here are most consistent with a secondary effect of fetal hyperinsulinemia on both Ep levels and erythropoiesis. This effect may be related to an increase in cellular proliferation and metabolism resulting in increased oxygen consumption. The fetus, being in a relatively hypoxic state compared to the adult may be more sensitive to changes in its internal environment. There is little direct evidence for fetal hypoxia in diabetic pregnancies in the absence ofadvanced vascular disease. The present data Erythropoietin in Infants of Diabetic Mothers 641I
are compatible with a major role for fetal insulin in the increased erythropoiesis of IDM.
